Home › Companies › UNITED THERAPEUTICS CORP. › 2024-2025

UNITED THERAPEUTICS CORP. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and UNITED THERAPEUTICS CORP.’s Form 8-K, filed June 27, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

15Ballot items
631Asset managers
10,808Fund votes
June 26, 2025Meeting date

Results at a glance

Meeting of June 26, 2025: 15 items on UNITED THERAPEUTICS CORP.’s Form 8-K, filed June 27, 2025: 15 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore UNITED THERAPEUTICS CORP. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by UNITED THERAPEUTICS CORP.

These tallies are UNITED THERAPEUTICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 27, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

UNITED THERAPEUTICS CORP. — official shareholder meeting results, meeting held June 26, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Christopher Causey	34,893,687	5,296,661	16,365	--	1,296,357	87%	Not verified	—
Elect Director: Raymond Dwek	36,254,579	3,935,774	16,360	--	1,296,357	90%	Not verified	—
Elect Director: Richard Giltner	37,971,706	2,218,884	16,123	--	1,296,357	94%	Not verified	—
Elect Director: Ray Kurzweil	38,353,526	1,836,845	16,342	--	1,296,357	95%	Not verified	—
Elect Director: Jan Malcolm	39,688,758	500,264	17,691	--	1,296,357	99%	Not verified	—
Elect Director: Linda Maxwell	39,715,114	474,450	17,149	--	1,296,357	99%	Not verified	—
Elect Director: Nilda Mesa	39,346,176	833,067	27,470	--	1,296,357	98%	Not verified	—
Elect Director: Judy Olian	39,832,045	357,023	17,645	--	1,296,357	99.1%	Not verified	—
Elect Director: Christopher Patusky	35,613,212	4,577,171	16,330	--	1,296,357	89%	Not verified	—
Elect Director: Martine Rothblatt	37,651,671	2,539,840	15,202	--	1,296,357	94%	Not verified	—
Elect Director: Louis Sullivan	36,302,169	3,875,030	29,514	--	1,296,357	90%	Not verified	—
Elect Director: Tommy Thompson	38,598,138	1,590,040	18,535	--	1,296,357	96%	Not verified	—
2. An advisory resolution to approve executive compensation	38,413,776	1,763,712	29,225	--	1,296,357	96%	Not verified	—
3. Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan	36,901,484	3,277,695	27,534	--	1,296,357	92%	Not verified	—
4. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025	39,345,917	2,142,852	14,301	--	--	95%	Not verified	—

Source: UNITED THERAPEUTICS CORP., Form 8-K, filed with the SEC on June 27, 2025 — read the filing on EDGAR.

How asset managers voted at the UNITED THERAPEUTICS CORP. 2024-2025 meeting

Each item below shows how the 631 asset managers that disclosed a UNITED THERAPEUTICS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Christopher Causey

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%

FOR: 34,893,687AGAINST: 5,296,661

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Christopher Causey

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Causey”): 34,893,687 for, 5,296,661 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 152 asset managers below reported 15,717,722 for, 1,290,959 against, 12,176 abstained, 22 not voted.

FOR

FOR: 15,717,722AGAINST: 1,290,959ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Christopher Causey” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,457	1	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	2,671	720,613	0	Against
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	0	232,026	0	Against
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	11,864	84,366	0	Mixed
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Equitable	83,150	0	0	For
Brighthouse	69,287	482	11,621	Mixed
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

2. Elect Director: Christopher Patusky

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%

FOR: 35,613,212AGAINST: 4,577,171

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Christopher Patusky

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Patusky”): 35,613,212 for, 4,577,171 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 152 asset managers below reported 16,235,927 for, 776,999 against, 12,176 abstained, 22 not voted.

FOR

FOR: 16,235,927AGAINST: 776,999ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Christopher Patusky” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,457	1	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	2,671	720,613	0	Against
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	Mixed
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

3. Elect Director: Jan Malcolm

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 39,688,758AGAINST: 500,264

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Jan Malcolm

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Jan Malcolm”): 39,688,758 for, 500,264 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 152 asset managers below reported 16,978,210 for, 34,716 against, 12,176 abstained, 22 not voted.

FOR

FOR: 16,978,210AGAINST: 34,716ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Jan Malcolm” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,395,458	0	For
BlackRock	2,949,135	0	For
Fidelity	2,104,599	0	For
State Street	723,284	0	For
Pacer Funds Trust	500,680	0	For
Capitol Series Trust	455,457	0	For
Charles Schwab	349,369	0	For
Invesco	331,976	0	For
First Trust	306,613	0	For
Victory Capital	303,730	0	For
TIAA	232,026	0	For
Lord Abbett	220,514	0	For
Thrivent	203,833	0	For
John Hancock	184,009	0	For
AQR	169,911	0	For
SEI	158,418	0	For
JPMorgan	112,335	0	For
Jackson National	96,230	0	For
Dimensional	95,632	0	For
T. Rowe Price	93,546	0	For
Brighthouse	74,014	11,621	Mixed
Equitable	83,150	0	For
AIG/SunAmerica	71,525	0	For
AllianceBernstein	71,517	0	For
Bridge Builder Trust	62,878	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

4. Elect Director: Judy Olian

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 39,832,045AGAINST: 357,023

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Judy Olian

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Judy Olian”): 39,832,045 for, 357,023 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 152 asset managers below reported 17,011,203 for, 1,723 against, 12,176 abstained, 22 not voted.

FOR

FOR: 17,011,203AGAINST: 1,723ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Judy Olian” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,395,458	0	For
BlackRock	2,949,135	0	For
Fidelity	2,104,599	0	For
State Street	723,284	0	For
Pacer Funds Trust	500,680	0	For
Capitol Series Trust	455,457	0	For
Charles Schwab	349,369	0	For
Invesco	331,976	0	For
First Trust	306,613	0	For
Victory Capital	303,730	0	For
TIAA	232,026	0	For
Lord Abbett	220,514	0	For
Thrivent	203,833	0	For
John Hancock	184,009	0	For
AQR	169,911	0	For
SEI	158,418	0	For
JPMorgan	112,335	0	For
Jackson National	96,230	0	For
Dimensional	95,632	0	For
T. Rowe Price	93,546	0	For
Brighthouse	74,014	11,621	Mixed
Equitable	83,150	0	For
AIG/SunAmerica	71,525	0	For
AllianceBernstein	71,517	0	For
Bridge Builder Trust	62,878	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

5. Elect Director: Linda Maxwell

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 39,715,114AGAINST: 474,450

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Linda Maxwell

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Linda Maxwell”): 39,715,114 for, 474,450 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 152 asset managers below reported 17,012,925 for, 0 against, 12,176 abstained, 22 not voted.

FOR

FOR: 17,012,925AGAINST: 0ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Linda Maxwell” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,395,458	0	For
BlackRock	2,949,135	0	For
Fidelity	2,104,599	0	For
State Street	723,284	0	For
Pacer Funds Trust	500,680	0	For
Capitol Series Trust	455,457	0	For
Charles Schwab	349,369	0	For
Invesco	331,976	0	For
First Trust	306,613	0	For
Victory Capital	303,730	0	For
TIAA	232,026	0	For
Lord Abbett	220,514	0	For
Thrivent	203,833	0	For
John Hancock	184,009	0	For
AQR	169,911	0	For
SEI	158,418	0	For
JPMorgan	112,335	0	For
Jackson National	96,230	0	For
Dimensional	95,632	0	For
T. Rowe Price	93,546	0	For
Brighthouse	74,014	11,621	Mixed
Equitable	83,150	0	For
AIG/SunAmerica	71,525	0	For
AllianceBernstein	71,517	0	For
Bridge Builder Trust	62,878	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

6. Elect Director: Louis Sullivan

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%

FOR: 36,302,169AGAINST: 3,875,030

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Louis Sullivan

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Louis Sullivan”): 36,302,169 for, 3,875,030 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 152 asset managers below reported 16,237,399 for, 775,527 against, 12,176 abstained, 22 not voted.

FOR

FOR: 16,237,399AGAINST: 775,527ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Louis Sullivan” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,457	1	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	2,671	720,613	0	Against
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	Mixed
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

7. Elect Director: Martine Rothblatt

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 37,651,671AGAINST: 2,539,840

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Martine Rothblatt

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Martine Rothblatt”): 37,651,671 for, 2,539,840 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 152 asset managers below reported 16,943,745 for, 69,181 against, 12,176 abstained, 22 not voted.

FOR

FOR: 16,943,745AGAINST: 69,181ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Martine Rothblatt” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,458	0	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	147,576	36,433	0	Mixed
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	Mixed
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

8. Elect Director: Nilda Mesa

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 39,346,176AGAINST: 833,067

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Nilda Mesa

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Nilda Mesa”): 39,346,176 for, 833,067 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 152 asset managers below reported 17,007,411 for, 5,515 against, 12,176 abstained, 22 not voted.

FOR

FOR: 17,007,411AGAINST: 5,515ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Nilda Mesa” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,395,458	0	For
BlackRock	2,949,135	0	For
Fidelity	2,104,599	0	For
State Street	723,284	0	For
Pacer Funds Trust	500,680	0	For
Capitol Series Trust	455,457	0	For
Charles Schwab	349,369	0	For
Invesco	331,976	0	For
First Trust	306,613	0	For
Victory Capital	303,730	0	For
TIAA	232,026	0	For
Lord Abbett	220,514	0	For
Thrivent	203,833	0	For
John Hancock	184,009	0	For
AQR	169,911	0	For
SEI	158,418	0	For
JPMorgan	112,335	0	For
Jackson National	96,230	0	For
Dimensional	95,632	0	For
T. Rowe Price	93,546	0	For
Brighthouse	74,014	11,621	Mixed
Equitable	83,150	0	For
AIG/SunAmerica	71,525	0	For
AllianceBernstein	71,517	0	For
Bridge Builder Trust	62,878	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

9. Elect Director: Ray Kurzweil

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 38,353,526AGAINST: 1,836,845

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Ray Kurzweil

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Ray Kurzweil”): 38,353,526 for, 1,836,845 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 152 asset managers below reported 16,946,439 for, 66,487 against, 12,176 abstained, 22 not voted.

FOR

FOR: 16,946,439AGAINST: 66,487ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Ray Kurzweil” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,458	0	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	Mixed
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

10. Elect Director: Raymond Dwek

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%

FOR: 36,254,579AGAINST: 3,935,774

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Raymond Dwek

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Raymond Dwek”): 36,254,579 for, 3,935,774 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 152 asset managers below reported 16,195,029 for, 817,897 against, 12,176 abstained, 22 not voted.

FOR

FOR: 16,195,029AGAINST: 817,897ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Raymond Dwek” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,457	1	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	2,671	720,613	0	Against
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	Mixed
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

11. Elect Director: Richard Giltner

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 37,971,706AGAINST: 2,218,884

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Richard Giltner

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Richard Giltner”): 37,971,706 for, 2,218,884 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 152 asset managers below reported 16,972,086 for, 40,840 against, 12,176 abstained, 22 not voted.

FOR

FOR: 16,972,086AGAINST: 40,840ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Richard Giltner” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,458	0	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	Mixed
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

12. Elect Director: Tommy Thompson

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 38,598,138AGAINST: 1,590,040

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: Election of Directors: Tommy Thompson

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Tommy Thompson”): 38,598,138 for, 1,590,040 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 152 asset managers below reported 16,975,877 for, 37,049 against, 12,176 abstained, 22 not voted.

FOR

FOR: 16,975,877AGAINST: 37,049ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “Election of Directors: Tommy Thompson” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,458	0	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	Mixed
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

13. 3. Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock…

Outcome not verified Fund totals may overlapCOMPENSATIONReported outcome: Not verified

Combines 6 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%

FOR: 36,901,484AGAINST: 3,277,695

Details: description as filed, official tally, votes by 158 asset managers

Description as filed by funds: APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN.

UNITED THERAPEUTICS CORP.’s own tally for this item (“3. Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan”): 36,901,484 for, 3,277,695 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STO” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,458	0	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	0	500,680	0	Against
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	11,864	84,366	0	Mixed
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	Mixed
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Fund voting reports, all 147 managers: 16,116,041 for, 811,060 against, 12,176 abstained, 22 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 11 asset managers voting on “APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STO” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Vote
Eversept Partners, LP	130,366	0	For
TOCQUEVILLE ASSET MANAGEMENT L.P.	0	33,900	Against
Erste Asset Management GmbH	25,341	0	For
Cardano Risk Management B.V.	18,794	0	For
Decatur Capital Management, Inc.	7,709	0	For
OSSIAM	1,456	0	For
EAGLE GLOBAL ADVISORS LLC	500	0	For
UNITED CAPITAL FINANCIAL ADVISORS, LLC	0	444	Against
LEAVELL INVESTMENT MANAGEMENT, INC.	0	0	--
Hendershot Investments Inc.	0	200	Against
BRANDYWINE OAK PRIVATE WEALTH LLC	81	0	For

Institutional-manager reports, all 11 managers: 184,247 for, 34,544 against, 411 unknown.

14. 2. An advisory resolution to approve executive compensation

Outcome not verified Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 12 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 38,413,776AGAINST: 1,763,712

Details: description as filed, official tally, votes by 628 asset managers

Description as filed by funds: Advisory resolution to approve executive compensation.

UNITED THERAPEUTICS CORP.’s own tally for this item (“2. An advisory resolution to approve executive compensation”): 38,413,776 for, 1,763,712 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Also reported under other wordings, matched to the same row of UNITED THERAPEUTICS CORP.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Compensation” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports: 147 asset managers voting on “Advisory resolution to approve executive compensation.” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,394,860	598	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,284	0	0	For
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	156,580	1,838	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	86,146	7,400	0	Mixed
Brighthouse	74,014	0	11,621	Mixed
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Fund voting reports, all 147 managers: 16,842,902 for, 94,290 against, 12,176 abstained, 22 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 513 asset managers voting on “Advisory resolution to approve executive compensation.” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Vote
State Street	2,077,850	0	For
BlackRock	2,009,396	293	For
Wellington	1,815,496	0	For
Renaissance	1,644,957	0	For
Avoro Capital Advisors LLC	1,249,329	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,217,495	0	For
Fidelity	1,208,421	0	For
AQR	562,904	0	For
LSV ASSET MANAGEMENT	523,185	0	For
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC	518,236	0	For
FULLER & THALER ASSET MANAGEMENT, INC.	474,881	0	For
FRONTIER CAPITAL MANAGEMENT CO LLC	209,748	209,748	Mixed
Invesco	403,003	0	For
DEERFIELD MANAGEMENT COMPANY, L.P.	386,744	0	For
Charles Schwab	354,590	0	For
Amundi	0	345,482	Against
AllianceBernstein	343,860	0	For
Northern Trust	335,044	0	For
Swedbank Robur Fonder AB	321,405	0	For
MELLON INVESTMENTS Corp	310,849	0	For
Epoch Investment Partners, Inc.	288,484	0	For
AustralianSuper Pty Ltd	284,616	0	For
Nuveen	274,092	0	For
ASSETMARK, INC	270,061	952	For
LORD, ABBETT & CO. LLC	261,991	0	For

Institutional-manager reports, all 513 managers: 25,289,298 for, 1,376,419 against, 6,057 abstained, 1,620 not voted, 411 unknown. Showing the 25 largest; see all in the interactive database.

15. 4. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 39,345,917AGAINST: 2,142,852

Details: description as filed, official tally, votes by 151 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2025.

UNITED THERAPEUTICS CORP.’s own tally for this item (“4. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025”): 39,345,917 for, 2,142,852 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 151 asset managers below reported 16,967,596 for, 26,536 against, 12,176 abstained, 22 not voted.

FOR

FOR: 16,967,596AGAINST: 26,536ABSTAIN: 12,176NOT VOTED: 22

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,394,860	598	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	73,532	482	11,621	Mixed
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 151 asset managers. See all 151 in the interactive database.

Largest UNITED THERAPEUTICS CORP. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 45,074,551 shares outstanding at the time of that meeting.

Fund voting reports: top UNITED THERAPEUTICS CORP. shareholders by shares voted on “Advisory resolution to approve executive compensation.”, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	11.97%
2	BlackRock	6.54%
3	Fidelity	4.67%
4	State Street	1.60%
5	Pacer Funds Trust	1.11%
6	Capitol Series Trust	1.01%
7	Charles Schwab	0.78%
8	Invesco	0.74%
9	First Trust	0.68%
10	Victory Capital	0.67%

Institutional-manager reports: top UNITED THERAPEUTICS CORP. shareholders by shares voted on “Advisory resolution to approve executive compensation.”, 2024-2025
#	Asset manager	% of shares outstanding
1	State Street	4.61%
2	BlackRock	4.46%
3	Wellington	4.03%
4	Renaissance	3.65%
5	Avoro Capital Advisors LLC	2.77%
6	GEODE CAPITAL MANAGEMENT, LLC	2.70%
7	Fidelity	2.68%
8	AQR	1.25%
9	LSV ASSET MANAGEMENT	1.16%
10	CAISSE DE DEPOT ET PLACEMENT DU QUEBEC	1.15%

Reported UNITED THERAPEUTICS CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

UNITED THERAPEUTICS CORP. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	12.08%	13F
Vanguard Group	9.89%	13F
Martine Rothblatt	7.09%	DEF14A
Avoro Capital Advisors LLC	6.34%	DEF14A
FMR LLC	5.15%	DEF14A
State Street	4.95%	13F
Renaissance Technologies	4.67%	13F
Wellington Management	4.50%	13F
FMR (Fidelity)	2.54%	13F
Dimensional Fund Advisors	1.39%	13F

Percentages above are of 45,074,551 shares outstanding, as reported by UNITED THERAPEUTICS CORP. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from UNITED THERAPEUTICS CORP.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At UNITED THERAPEUTICS CORP.'s shareholder meeting held June 26, 2025, in the 2024-2025 proxy season, 631 asset managers reported how they voted on 15 ballot items in their SEC Form N-PX filings, covering 10,808 separate fund positions. On the most widely held item on that ballot — Advisory resolution to approve executive compensation. — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: UNITED THERAPEUTICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 27, 2025.

UNITED THERAPEUTICS CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.